CBIO
Crescent Biopharma
CBIO
CBIO
50 hedge funds and large institutions have $115M invested in Crescent Biopharma in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.82% more ownership
Funds ownership: 0% → 0.82% (+0.82%)
12% less capital invested
Capital invested by funds: $131M → $115M (-$15.9M)
Holders
50
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.5M | |
| 2 | +$475K | |
| 3 | +$317K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$231K |
| 5 |
Morgan Stanley
New York
|
+$205K |
Top Sellers
| 1 | -$925K | |
| 2 | -$175K | |
| 3 | -$101K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$99K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
-$84.2K |